Tapewire

Nasdaq · USD

TIPT

TIPTREE INC.

Export transactions ↓
Tapewire entity
5239
SEC CIK
0001393726
Parsed reports
515

Last 12 months

Inside the activity.

4 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 202600
Mar 202620
Apr 202600
May 202610
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 14, 2019 Filed May 15, 2019 09:31 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 32 $5.91 $189.12
Disclosure

SEC source: 0001393726-19-000094 · wf-form4_155792708427946.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,819,171

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
May 13, 2019 Filed May 14, 2019 10:06 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 183 $5.95 $1,088.85
Disclosure

SEC source: 0001393726-19-000092 · wf-form4_155784279731661.xml · nonDerivative · entry 11

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,819,139

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
May 13, 2019 Filed May 14, 2019 10:06 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 470 $5.94 $2,791.80
Disclosure

SEC source: 0001393726-19-000092 · wf-form4_155784279731661.xml · nonDerivative · entry 10

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,818,956

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
May 13, 2019 Filed May 14, 2019 10:06 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 3,501 $5.92 $20,725.92
Disclosure

SEC source: 0001393726-19-000092 · wf-form4_155784279731661.xml · nonDerivative · entry 9

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,818,486

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
May 13, 2019 Filed May 14, 2019 10:06 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 496 $5.91 $2,931.36
Disclosure

SEC source: 0001393726-19-000092 · wf-form4_155784279731661.xml · nonDerivative · entry 8

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,814,985

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
May 13, 2019 Filed May 14, 2019 10:06 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 379 $5.90 $2,236.10
Disclosure

SEC source: 0001393726-19-000092 · wf-form4_155784279731661.xml · nonDerivative · entry 7

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,814,489

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
May 13, 2019 Filed May 14, 2019 10:06 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 473 $5.88 $2,781.24
Disclosure

SEC source: 0001393726-19-000092 · wf-form4_155784279731661.xml · nonDerivative · entry 6

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,814,110

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
May 10, 2019 Filed May 14, 2019 10:06 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 420 $5.92 $2,486.40
Disclosure

SEC source: 0001393726-19-000092 · wf-form4_155784279731661.xml · nonDerivative · entry 5

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,813,637

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
May 10, 2019 Filed May 14, 2019 10:06 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 325 $5.91 $1,920.75
Disclosure

SEC source: 0001393726-19-000092 · wf-form4_155784279731661.xml · nonDerivative · entry 4

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,813,217

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
May 10, 2019 Filed May 14, 2019 10:06 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 2,194 $5.90 $12,944.60
Disclosure

SEC source: 0001393726-19-000092 · wf-form4_155784279731661.xml · nonDerivative · entry 3

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,812,892

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
May 10, 2019 Filed May 14, 2019 10:06 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 1,045 $5.89 $6,155.05
Disclosure

SEC source: 0001393726-19-000092 · wf-form4_155784279731661.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,810,698

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
May 10, 2019 Filed May 14, 2019 10:06 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 139 $5.88 $817.32
Disclosure

SEC source: 0001393726-19-000092 · wf-form4_155784279731661.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,809,653

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
May 08, 2019 Filed May 9, 2019 14:07 UTC
Ilany JonathanDirector · Chief Executive Officer
PurchaseCommon Stock 4,500 $5.93 $26,685.00
Disclosure

SEC source: 0001393726-19-000090 · wf-form4_155741083630655.xml · nonDerivative · entry 2

Ilany Jonathan · CIK 0001499150 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By 401K

Disclosed balance after: 24,650

Read SEC document
April 18, 2019 Filed Apr 18, 2019 15:57 UTC
Bell SandraChief Financial Officer
SaleCommon Stock 390 $6.34 $2,472.60
Disclosure

SEC source: 0001393726-19-000081 · wf-form4_155561744036456.xml · nonDerivative · entry 3

Bell Sandra · CIK 0001447887 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,141

F1 · shares: Pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 17, 2019 Filed Apr 18, 2019 15:57 UTC
Bell SandraChief Financial Officer
SaleCommon Stock 400 $6.34 $2,536.00
Disclosure

SEC source: 0001393726-19-000081 · wf-form4_155561744036456.xml · nonDerivative · entry 2

Bell Sandra · CIK 0001447887 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,531

F1 · shares: Pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 16, 2019 Filed Apr 18, 2019 15:57 UTC
Bell SandraChief Financial Officer
SaleCommon Stock 400 $6.35 $2,540.00
Disclosure

SEC source: 0001393726-19-000081 · wf-form4_155561744036456.xml · nonDerivative · entry 1

Bell Sandra · CIK 0001447887 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,931

F1 · shares: Pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 15, 2019 Filed Apr 16, 2019 09:51 UTC
Bell SandraChief Financial Officer
SaleCommon Stock 400 $6.30 $2,520.00
Disclosure

SEC source: 0001393726-19-000079 · wf-form4_155542265487935.xml · nonDerivative · entry 2

Bell Sandra · CIK 0001447887 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,331

F1 · shares: Pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 12, 2019 Filed Apr 16, 2019 09:51 UTC
Bell SandraChief Financial Officer
SaleCommon Stock 400 $6.34 $2,536.00
Disclosure

SEC source: 0001393726-19-000079 · wf-form4_155542265487935.xml · nonDerivative · entry 1

Bell Sandra · CIK 0001447887 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,731

F1 · shares: Pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 11, 2019 Filed Apr 12, 2019 10:39 UTC
Bell SandraChief Financial Officer
SaleCommon Stock 400 $6.25 $2,500.00
Disclosure

SEC source: 0001393726-19-000077 · wf-form4_155507993213936.xml · nonDerivative · entry 2

Bell Sandra · CIK 0001447887 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,131

F1 · shares: Pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 10, 2019 Filed Apr 12, 2019 10:39 UTC
Bell SandraChief Financial Officer
SaleCommon Stock 400 $6.28 $2,512.00
Disclosure

SEC source: 0001393726-19-000077 · wf-form4_155507993213936.xml · nonDerivative · entry 1

Bell Sandra · CIK 0001447887 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,531

F1 · shares: Pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 09, 2019 Filed Apr 10, 2019 09:58 UTC
Bell SandraChief Financial Officer
SaleCommon Stock 400 $6.32 $2,528.00
Disclosure

SEC source: 0001393726-19-000075 · wf-form4_155490467175304.xml · nonDerivative · entry 2

Bell Sandra · CIK 0001447887 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,931

F1 · shares: Pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 08, 2019 Filed Apr 10, 2019 09:58 UTC
Bell SandraChief Financial Officer
SaleCommon Stock 400 $6.34 $2,536.00
Disclosure

SEC source: 0001393726-19-000075 · wf-form4_155490467175304.xml · nonDerivative · entry 1

Bell Sandra · CIK 0001447887 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,331

F1 · shares: Pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 05, 2019 Filed Apr 8, 2019 13:07 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 1,504 $6.35 $9,550.40
Disclosure

SEC source: 0001393726-19-000071 · wf-form4_155474323593526.xml · nonDerivative · entry 5

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,809,514

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 05, 2019 Filed Apr 8, 2019 13:07 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 6 $6.34 $38.04
Disclosure

SEC source: 0001393726-19-000071 · wf-form4_155474323593526.xml · nonDerivative · entry 4

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,808,010

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 05, 2019 Filed Apr 8, 2019 13:10 UTC
Bell SandraChief Financial Officer
SaleCommon Stock 400 $6.34 $2,536.00
Disclosure

SEC source: 0001393726-19-000073 · wf-form4_155474339366531.xml · nonDerivative · entry 2

Bell Sandra · CIK 0001447887 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,731

F1 · shares: Pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 04, 2019 Filed Apr 8, 2019 13:07 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 2,694 $6.37 $17,160.78
Disclosure

SEC source: 0001393726-19-000071 · wf-form4_155474323593526.xml · nonDerivative · entry 3

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,808,004

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 04, 2019 Filed Apr 8, 2019 13:07 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 5,497 $6.36 $34,960.92
Disclosure

SEC source: 0001393726-19-000071 · wf-form4_155474323593526.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,805,310

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 04, 2019 Filed Apr 8, 2019 13:07 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 496 $6.35 $3,149.60
Disclosure

SEC source: 0001393726-19-000071 · wf-form4_155474323593526.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,799,813

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 04, 2019 Filed Apr 8, 2019 13:10 UTC
Bell SandraChief Financial Officer
SaleCommon Stock 400 $6.34 $2,536.00
Disclosure

SEC source: 0001393726-19-000073 · wf-form4_155474339366531.xml · nonDerivative · entry 1

Bell Sandra · CIK 0001447887 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,131

F1 · shares: Pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 03, 2019 Filed Apr 4, 2019 11:08 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 5,347 $6.36 $34,006.92
Disclosure

SEC source: 0001393726-19-000068 · wf-form4_155439047168702.xml · nonDerivative · entry 5

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,799,317

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 03, 2019 Filed Apr 4, 2019 11:08 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 53,364 $6.35 $338,861.40
Disclosure

SEC source: 0001393726-19-000068 · wf-form4_155439047168702.xml · nonDerivative · entry 4

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,793,970

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 03, 2019 Filed Apr 4, 2019 11:08 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 300 $6.34 $1,902.00
Disclosure

SEC source: 0001393726-19-000068 · wf-form4_155439047168702.xml · nonDerivative · entry 3

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,740,606

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 03, 2019 Filed Apr 4, 2019 11:05 UTC
Bell SandraChief Financial Officer
SaleCommon Stock 400 $6.35 $2,540.00
Disclosure

SEC source: 0001393726-19-000066 · wf-form4_155439029227851.xml · nonDerivative · entry 2

Bell Sandra · CIK 0001447887 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,531

F1 · shares: Pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 02, 2019 Filed Apr 2, 2019 14:52 UTC GrantCommon Stock 2,982 $0.00 $0.00
Disclosure

SEC source: 0001393726-19-000060 · wf-form4_155421672261624.xml · nonDerivative · entry 1

Goldwasser Lesley · CIK 0001465575 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,743

F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears.

Read SEC document
April 02, 2019 Filed Apr 2, 2019 10:49 UTC GrantCommon Stock 2,982 $0.00 $0.00
Disclosure

SEC source: 0001393726-19-000058 · wf-form4_155421657702796.xml · nonDerivative · entry 1

Friedman Paul M · CIK 0001648181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,403

F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears.

Read SEC document
April 02, 2019 Filed Apr 2, 2019 10:57 UTC GrantCommon Stock 2,982 $0.00 $0.00
Disclosure

SEC source: 0001393726-19-000064 · wf-form4_155421701213987.xml · nonDerivative · entry 1

Smith Bradley E. · CIK 0001579089 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,400

F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears.

Read SEC document
April 02, 2019 Filed Apr 2, 2019 10:55 UTC GrantCommon Stock 2,982 $0.00 $0.00
Disclosure

SEC source: 0001393726-19-000062 · wf-form4_155421688650154.xml · nonDerivative · entry 1

Mack John Edward · CIK 0001381172 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,848

F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears.

Read SEC document
April 02, 2019 Filed Apr 4, 2019 11:08 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 846 $6.32 $5,346.72
Disclosure

SEC source: 0001393726-19-000068 · wf-form4_155439047168702.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,740,306

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 02, 2019 Filed Apr 4, 2019 11:08 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 600 $6.31 $3,786.00
Disclosure

SEC source: 0001393726-19-000068 · wf-form4_155439047168702.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,739,460

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 02, 2019 Filed Apr 4, 2019 11:05 UTC
Bell SandraChief Financial Officer
SaleCommon Stock 400 $6.32 $2,528.00
Disclosure

SEC source: 0001393726-19-000066 · wf-form4_155439029227851.xml · nonDerivative · entry 1

Bell Sandra · CIK 0001447887 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,931

F1 · shares: Pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 01, 2019 Filed Apr 2, 2019 10:47 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 44,613 $6.35 $283,292.55
Disclosure

SEC source: 0001393726-19-000056 · wf-form4_155421643457770.xml · nonDerivative · entry 10

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,738,860

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 01, 2019 Filed Apr 2, 2019 10:47 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 1,947 $6.34 $12,343.98
Disclosure

SEC source: 0001393726-19-000056 · wf-form4_155421643457770.xml · nonDerivative · entry 9

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,694,247

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 01, 2019 Filed Apr 2, 2019 10:47 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 160 $6.33 $1,012.80
Disclosure

SEC source: 0001393726-19-000056 · wf-form4_155421643457770.xml · nonDerivative · entry 8

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,692,300

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 01, 2019 Filed Apr 2, 2019 10:43 UTC
Bell SandraChief Financial Officer
SaleCommon Stock 400 $6.35 $2,540.00
Disclosure

SEC source: 0001393726-19-000054 · wf-form4_155421621173457.xml · nonDerivative · entry 2

Bell Sandra · CIK 0001447887 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,331

F1 · shares: Pursuant to a Rule 10b5-1 trading plan.

Read SEC document
March 29, 2019 Filed Apr 2, 2019 10:47 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 1,600 $6.39 $10,224.00
Disclosure

SEC source: 0001393726-19-000056 · wf-form4_155421643457770.xml · nonDerivative · entry 7

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,692,140

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
March 29, 2019 Filed Apr 2, 2019 10:47 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 2,000 $6.38 $12,760.00
Disclosure

SEC source: 0001393726-19-000056 · wf-form4_155421643457770.xml · nonDerivative · entry 6

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,690,540

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
March 29, 2019 Filed Apr 2, 2019 10:47 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 1,500 $6.37 $9,555.00
Disclosure

SEC source: 0001393726-19-000056 · wf-form4_155421643457770.xml · nonDerivative · entry 5

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,688,540

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
March 29, 2019 Filed Apr 2, 2019 10:47 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 1,557 $6.35 $9,886.95
Disclosure

SEC source: 0001393726-19-000056 · wf-form4_155421643457770.xml · nonDerivative · entry 4

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,687,040

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
March 29, 2019 Filed Apr 2, 2019 10:47 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 3,448 $6.34 $21,860.32
Disclosure

SEC source: 0001393726-19-000056 · wf-form4_155421643457770.xml · nonDerivative · entry 3

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,685,483

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
March 29, 2019 Filed Apr 2, 2019 10:47 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 7,370 $6.33 $46,652.10
Disclosure

SEC source: 0001393726-19-000056 · wf-form4_155421643457770.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,682,035

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.